nodes	percent_of_prediction	percent_of_DWPC	metapath
Methadone—CYP2C18—prostate cancer	0.124	0.333	CbGaD
Methadone—CYP3A5—prostate cancer	0.0818	0.22	CbGaD
Methadone—CYP19A1—prostate cancer	0.0754	0.202	CbGaD
Methadone—CYP2C19—prostate cancer	0.0557	0.149	CbGaD
Methadone—CYP3A4—prostate cancer	0.0354	0.095	CbGaD
Methadone—CYP2C8—Nilutamide—prostate cancer	0.0162	0.04	CbGbCtD
Methadone—CYP3A5—Flutamide—prostate cancer	0.0139	0.0345	CbGbCtD
Methadone—CYP2C19—Bicalutamide—prostate cancer	0.0135	0.0336	CbGbCtD
Methadone—CYP2C19—Nilutamide—prostate cancer	0.0135	0.0336	CbGbCtD
Methadone—CYP2C8—Abiraterone—prostate cancer	0.0134	0.0332	CbGbCtD
Methadone—CYP2B6—Estrone—prostate cancer	0.0128	0.0317	CbGbCtD
Methadone—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0125	0.0309	CbGbCtD
Methadone—CYP2B6—Ethinyl Estradiol—prostate cancer	0.0114	0.0282	CbGbCtD
Methadone—CYP2C9—Nilutamide—prostate cancer	0.0113	0.0279	CbGbCtD
Methadone—CYP2C9—Bicalutamide—prostate cancer	0.0113	0.0279	CbGbCtD
Methadone—CYP2C19—Flutamide—prostate cancer	0.0112	0.0278	CbGbCtD
Methadone—CYP1A2—Flutamide—prostate cancer	0.0104	0.0257	CbGbCtD
Methadone—CYP2D6—Bicalutamide—prostate cancer	0.0103	0.0255	CbGbCtD
Methadone—CYP3A5—Cabazitaxel—prostate cancer	0.0103	0.0255	CbGbCtD
Methadone—ABCB1—Estramustine—prostate cancer	0.0102	0.0252	CbGbCtD
Methadone—CYP3A5—Estrone—prostate cancer	0.0101	0.025	CbGbCtD
Methadone—CYP2C8—Cabazitaxel—prostate cancer	0.0099	0.0245	CbGbCtD
Methadone—CYP2C8—Ethinyl Estradiol—prostate cancer	0.00862	0.0214	CbGbCtD
Methadone—CYP2D6—Abiraterone—prostate cancer	0.00854	0.0212	CbGbCtD
Methadone—CYP3A7—Estradiol—prostate cancer	0.00771	0.0191	CbGbCtD
Methadone—CYP3A7-CYP3A51P—Estradiol—prostate cancer	0.00771	0.0191	CbGbCtD
Methadone—CYP1A2—Estrone—prostate cancer	0.00749	0.0186	CbGbCtD
Methadone—CYP2C9—Estrone—prostate cancer	0.00675	0.0167	CbGbCtD
Methadone—ABCB1—Cabazitaxel—prostate cancer	0.0067	0.0166	CbGbCtD
Methadone—CYP3A4—Bicalutamide—prostate cancer	0.00655	0.0162	CbGbCtD
Methadone—ABCB1—Estrone—prostate cancer	0.00655	0.0162	CbGbCtD
Methadone—CYP3A4—Estramustine—prostate cancer	0.00609	0.0151	CbGbCtD
Methadone—ABCB1—Ethinyl Estradiol—prostate cancer	0.00584	0.0145	CbGbCtD
Methadone—CYP3A5—Estradiol—prostate cancer	0.00578	0.0143	CbGbCtD
Methadone—CYP2C8—Estradiol—prostate cancer	0.00556	0.0138	CbGbCtD
Methadone—CYP3A4—Abiraterone—prostate cancer	0.00543	0.0135	CbGbCtD
Methadone—CYP3A4—Flutamide—prostate cancer	0.00543	0.0135	CbGbCtD
Methadone—CYP2C9—Capecitabine—prostate cancer	0.00511	0.0127	CbGbCtD
Methadone—CYP1A2—Conjugated Estrogens—prostate cancer	0.0049	0.0121	CbGbCtD
Methadone—CYP2C19—Estradiol—prostate cancer	0.00466	0.0116	CbGbCtD
Methadone—CYP3A7—Docetaxel—prostate cancer	0.0046	0.0114	CbGbCtD
Methadone—CYP3A7-CYP3A51P—Docetaxel—prostate cancer	0.0046	0.0114	CbGbCtD
Methadone—CYP1A2—Estradiol—prostate cancer	0.0043	0.0107	CbGbCtD
Methadone—ABCB1—Conjugated Estrogens—prostate cancer	0.00428	0.0106	CbGbCtD
Methadone—CYP3A4—Cabazitaxel—prostate cancer	0.00401	0.00995	CbGbCtD
Methadone—CYP2C19—Prednisone—prostate cancer	0.00401	0.00994	CbGbCtD
Methadone—CYP3A4—Estrone—prostate cancer	0.00392	0.00973	CbGbCtD
Methadone—ABCB1—Mitoxantrone—prostate cancer	0.00389	0.00966	CbGbCtD
Methadone—CYP2C9—Estradiol—prostate cancer	0.00388	0.00961	CbGbCtD
Methadone—CYP3A5—Etoposide—prostate cancer	0.00377	0.00936	CbGbCtD
Methadone—ABCB1—Estradiol—prostate cancer	0.00376	0.00933	CbGbCtD
Methadone—CYP2C8—Etoposide—prostate cancer	0.00363	0.009	CbGbCtD
Methadone—CYP3A4—Ethinyl Estradiol—prostate cancer	0.0035	0.00867	CbGbCtD
Methadone—CYP3A5—Docetaxel—prostate cancer	0.00345	0.00856	CbGbCtD
Methadone—CYP2B6—Doxorubicin—prostate cancer	0.00327	0.0081	CbGbCtD
Methadone—ABCB1—Prednisone—prostate cancer	0.00323	0.00802	CbGbCtD
Methadone—CYP1A2—Etoposide—prostate cancer	0.00281	0.00696	CbGbCtD
Methadone—CYP3A4—Conjugated Estrogens—prostate cancer	0.00257	0.00637	CbGbCtD
Methadone—ABCB1—Etoposide—prostate cancer	0.00246	0.00609	CbGbCtD
Methadone—CYP19A1—semen—prostate cancer	0.00242	0.15	CbGeAlD
Methadone—CYP3A4—Mitoxantrone—prostate cancer	0.00233	0.00579	CbGbCtD
Methadone—CYP3A4—Estradiol—prostate cancer	0.00225	0.00559	CbGbCtD
Methadone—ABCB1—Docetaxel—prostate cancer	0.00225	0.00557	CbGbCtD
Methadone—CYP3A4—Prednisone—prostate cancer	0.00194	0.00481	CbGbCtD
Methadone—ABCB1—Doxorubicin—prostate cancer	0.00168	0.00415	CbGbCtD
Methadone—CYP2D6—Doxorubicin—prostate cancer	0.00158	0.00391	CbGbCtD
Methadone—CYP3A4—Etoposide—prostate cancer	0.00147	0.00365	CbGbCtD
Methadone—CYP2C19—urine—prostate cancer	0.00139	0.0856	CbGeAlD
Methadone—CYP3A4—Docetaxel—prostate cancer	0.00135	0.00334	CbGbCtD
Methadone—CYP1A2—urine—prostate cancer	0.00113	0.0699	CbGeAlD
Methadone—CYP2C9—urine—prostate cancer	0.00108	0.0664	CbGeAlD
Methadone—OPRK1—prostate gland—prostate cancer	0.00102	0.0627	CbGeAlD
Methadone—CYP3A4—Doxorubicin—prostate cancer	0.001	0.00249	CbGbCtD
Methadone—CYP3A4—urine—prostate cancer	0.00082	0.0506	CbGeAlD
Methadone—CYP2D6—urine—prostate cancer	0.000807	0.0498	CbGeAlD
Methadone—CHRNA10—testis—prostate cancer	0.00075	0.0463	CbGeAlD
Methadone—OPRD1—renal system—prostate cancer	0.000722	0.0446	CbGeAlD
Methadone—GRIN3A—testis—prostate cancer	0.000662	0.0409	CbGeAlD
Methadone—CYP19A1—prostate gland—prostate cancer	0.000607	0.0375	CbGeAlD
Methadone—CHRNA10—lymph node—prostate cancer	0.000543	0.0336	CbGeAlD
Methadone—CYP3A5—prostate gland—prostate cancer	0.000392	0.0242	CbGeAlD
Methadone—OPRM1—testis—prostate cancer	0.000318	0.0197	CbGeAlD
Methadone—CYP2C8—renal system—prostate cancer	0.000296	0.0183	CbGeAlD
Methadone—CYP1A2—renal system—prostate cancer	0.000277	0.0171	CbGeAlD
Methadone—CYP19A1—testis—prostate cancer	0.000267	0.0165	CbGeAlD
Methadone—CYP3A5—renal system—prostate cancer	0.000267	0.0165	CbGeAlD
Methadone—CYP2B6—renal system—prostate cancer	0.000266	0.0164	CbGeAlD
Methadone—Tamoxifen—SULT1A1—prostate cancer	0.000237	0.0896	CrCbGaD
Methadone—ABCB1—prostate gland—prostate cancer	0.000208	0.0129	CbGeAlD
Methadone—CYP3A4—renal system—prostate cancer	0.000201	0.0124	CbGeAlD
Methadone—CYP2D6—renal system—prostate cancer	0.000197	0.0122	CbGeAlD
Methadone—CYP19A1—lymph node—prostate cancer	0.000194	0.012	CbGeAlD
Methadone—CYP2C8—testis—prostate cancer	0.000191	0.0118	CbGeAlD
Methadone—ABCB1—seminal vesicle—prostate cancer	0.000176	0.0109	CbGeAlD
Methadone—CYP2B6—testis—prostate cancer	0.000172	0.0106	CbGeAlD
Methadone—ABCB1—epithelium—prostate cancer	0.000153	0.00945	CbGeAlD
Methadone—Clotrimazole—CYP17A1—prostate cancer	0.000148	0.0561	CrCbGaD
Methadone—ABCB1—renal system—prostate cancer	0.000142	0.00877	CbGeAlD
Methadone—ABCB1—urethra—prostate cancer	0.000139	0.00861	CbGeAlD
Methadone—CYP2D6—testis—prostate cancer	0.000128	0.00788	CbGeAlD
Methadone—Disopyramide—SLC22A1—prostate cancer	0.000124	0.0471	CrCbGaD
Methadone—ABCB1—bone marrow—prostate cancer	0.000107	0.00663	CbGeAlD
Methadone—Phenoxybenzamine—SLC22A3—prostate cancer	0.000102	0.0387	CrCbGaD
Methadone—ABCB1—testis—prostate cancer	9.18e-05	0.00567	CbGeAlD
Methadone—Levomethadyl Acetate—CYP3A5—prostate cancer	8.18e-05	0.031	CrCbGaD
Methadone—Clotrimazole—CYP2A6—prostate cancer	7.92e-05	0.03	CrCbGaD
Methadone—Diphenhydramine—CYP2C18—prostate cancer	7.54e-05	0.0285	CrCbGaD
Methadone—Clotrimazole—CYP19A1—prostate cancer	7.54e-05	0.0285	CrCbGaD
Methadone—Levomethadyl Acetate—CYP19A1—prostate cancer	7.54e-05	0.0285	CrCbGaD
Methadone—Phenoxybenzamine—SLC22A1—prostate cancer	7.34e-05	0.0278	CrCbGaD
Methadone—Modafinil—CYP3A5—prostate cancer	7.15e-05	0.0271	CrCbGaD
Methadone—Fentanyl—CYP3A5—prostate cancer	6.99e-05	0.0265	CrCbGaD
Methadone—Tamoxifen—ESR2—prostate cancer	6.66e-05	0.0252	CrCbGaD
Methadone—ABCB1—lymph node—prostate cancer	6.65e-05	0.00411	CbGeAlD
Methadone—Diphenhydramine—SLC22A1—prostate cancer	6.16e-05	0.0233	CrCbGaD
Methadone—Tamoxifen—CYP1B1—prostate cancer	6.07e-05	0.023	CrCbGaD
Methadone—Feeling abnormal—Mitoxantrone—prostate cancer	6.03e-05	0.000556	CcSEcCtD
Methadone—Erythema—Capecitabine—prostate cancer	6e-05	0.000553	CcSEcCtD
Methadone—Gastrointestinal pain—Mitoxantrone—prostate cancer	5.99e-05	0.000551	CcSEcCtD
Methadone—Thrombocytopenia—Etoposide—prostate cancer	5.96e-05	0.000549	CcSEcCtD
Methadone—Muscle spasms—Docetaxel—prostate cancer	5.96e-05	0.000549	CcSEcCtD
Methadone—Tachycardia—Etoposide—prostate cancer	5.94e-05	0.000547	CcSEcCtD
Methadone—Nausea—Goserelin—prostate cancer	5.89e-05	0.000542	CcSEcCtD
Methadone—Hyperhidrosis—Etoposide—prostate cancer	5.89e-05	0.000542	CcSEcCtD
Methadone—Orthostatic hypotension—Doxorubicin—prostate cancer	5.87e-05	0.000541	CcSEcCtD
Methadone—Oxaprozin—PTGS2—prostate cancer	5.85e-05	0.0221	CrCbGaD
Methadone—Hypokalaemia—Doxorubicin—prostate cancer	5.85e-05	0.000539	CcSEcCtD
Methadone—Nausea—Conjugated Estrogens—prostate cancer	5.83e-05	0.000537	CcSEcCtD
Methadone—Urticaria—Mitoxantrone—prostate cancer	5.82e-05	0.000536	CcSEcCtD
Methadone—Anorexia—Etoposide—prostate cancer	5.8e-05	0.000535	CcSEcCtD
Methadone—Hypersensitivity—Estradiol—prostate cancer	5.79e-05	0.000533	CcSEcCtD
Methadone—Abdominal pain—Mitoxantrone—prostate cancer	5.79e-05	0.000533	CcSEcCtD
Methadone—Body temperature increased—Mitoxantrone—prostate cancer	5.79e-05	0.000533	CcSEcCtD
Methadone—Muscle spasms—Capecitabine—prostate cancer	5.77e-05	0.000532	CcSEcCtD
Methadone—Nasopharyngitis—Doxorubicin—prostate cancer	5.75e-05	0.000529	CcSEcCtD
Methadone—Flushing—Prednisone—prostate cancer	5.7e-05	0.000525	CcSEcCtD
Methadone—Hypotension—Etoposide—prostate cancer	5.69e-05	0.000524	CcSEcCtD
Methadone—Asthenia—Estradiol—prostate cancer	5.64e-05	0.000519	CcSEcCtD
Methadone—Tremor—Capecitabine—prostate cancer	5.62e-05	0.000518	CcSEcCtD
Methadone—Clotrimazole—CYP2E1—prostate cancer	5.62e-05	0.0213	CrCbGaD
Methadone—Clotrimazole—CYP2C19—prostate cancer	5.57e-05	0.0211	CrCbGaD
Methadone—Syncope—Docetaxel—prostate cancer	5.56e-05	0.000512	CcSEcCtD
Methadone—Pruritus—Estradiol—prostate cancer	5.56e-05	0.000512	CcSEcCtD
Methadone—Arrhythmia—Prednisone—prostate cancer	5.49e-05	0.000506	CcSEcCtD
Methadone—Palpitations—Docetaxel—prostate cancer	5.48e-05	0.000505	CcSEcCtD
Methadone—Weight increased—Epirubicin—prostate cancer	5.46e-05	0.000503	CcSEcCtD
Methadone—Loss of consciousness—Docetaxel—prostate cancer	5.45e-05	0.000502	CcSEcCtD
Methadone—Weight decreased—Epirubicin—prostate cancer	5.43e-05	0.0005	CcSEcCtD
Methadone—Somnolence—Etoposide—prostate cancer	5.41e-05	0.000499	CcSEcCtD
Methadone—Vertigo—Capecitabine—prostate cancer	5.39e-05	0.000497	CcSEcCtD
Methadone—Hypersensitivity—Mitoxantrone—prostate cancer	5.39e-05	0.000497	CcSEcCtD
Methadone—Syncope—Capecitabine—prostate cancer	5.38e-05	0.000496	CcSEcCtD
Methadone—Diarrhoea—Estradiol—prostate cancer	5.38e-05	0.000495	CcSEcCtD
Methadone—Convulsion—Docetaxel—prostate cancer	5.37e-05	0.000495	CcSEcCtD
Methadone—Drowsiness—Epirubicin—prostate cancer	5.35e-05	0.000493	CcSEcCtD
Methadone—Erythema—Prednisone—prostate cancer	5.35e-05	0.000493	CcSEcCtD
Methadone—Palpitations—Capecitabine—prostate cancer	5.3e-05	0.000489	CcSEcCtD
Methadone—Decreased appetite—Etoposide—prostate cancer	5.29e-05	0.000488	CcSEcCtD
Methadone—Loss of consciousness—Capecitabine—prostate cancer	5.28e-05	0.000486	CcSEcCtD
Methadone—Asthenia—Mitoxantrone—prostate cancer	5.25e-05	0.000484	CcSEcCtD
Methadone—Constipation—Etoposide—prostate cancer	5.21e-05	0.00048	CcSEcCtD
Methadone—Pain—Etoposide—prostate cancer	5.21e-05	0.00048	CcSEcCtD
Methadone—Dizziness—Estradiol—prostate cancer	5.2e-05	0.000479	CcSEcCtD
Methadone—Dry mouth—Docetaxel—prostate cancer	5.16e-05	0.000476	CcSEcCtD
Methadone—Sweating—Epirubicin—prostate cancer	5.13e-05	0.000473	CcSEcCtD
Methadone—Confusional state—Docetaxel—prostate cancer	5.1e-05	0.00047	CcSEcCtD
Methadone—Anxiety—Capecitabine—prostate cancer	5.09e-05	0.000469	CcSEcCtD
Methadone—Anaphylactic shock—Docetaxel—prostate cancer	5.06e-05	0.000466	CcSEcCtD
Methadone—Oedema—Docetaxel—prostate cancer	5.06e-05	0.000466	CcSEcCtD
Methadone—Weight increased—Doxorubicin—prostate cancer	5.05e-05	0.000466	CcSEcCtD
Methadone—Weight decreased—Doxorubicin—prostate cancer	5.02e-05	0.000463	CcSEcCtD
Methadone—Feeling abnormal—Etoposide—prostate cancer	5.02e-05	0.000462	CcSEcCtD
Methadone—Diarrhoea—Mitoxantrone—prostate cancer	5.01e-05	0.000461	CcSEcCtD
Methadone—Dry mouth—Capecitabine—prostate cancer	5e-05	0.00046	CcSEcCtD
Methadone—Vomiting—Estradiol—prostate cancer	5e-05	0.00046	CcSEcCtD
Methadone—Gastrointestinal pain—Etoposide—prostate cancer	4.98e-05	0.000459	CcSEcCtD
Methadone—Shock—Docetaxel—prostate cancer	4.98e-05	0.000459	CcSEcCtD
Methadone—Thrombocytopenia—Docetaxel—prostate cancer	4.95e-05	0.000456	CcSEcCtD
Methadone—Rash—Estradiol—prostate cancer	4.95e-05	0.000456	CcSEcCtD
Methadone—Drowsiness—Doxorubicin—prostate cancer	4.95e-05	0.000456	CcSEcCtD
Methadone—Dermatitis—Estradiol—prostate cancer	4.95e-05	0.000456	CcSEcCtD
Methadone—Confusional state—Capecitabine—prostate cancer	4.94e-05	0.000455	CcSEcCtD
Methadone—Tachycardia—Docetaxel—prostate cancer	4.94e-05	0.000455	CcSEcCtD
Methadone—Headache—Estradiol—prostate cancer	4.92e-05	0.000453	CcSEcCtD
Methadone—Alimemazine—CYP3A4—prostate cancer	4.92e-05	0.0186	CrCbGaD
Methadone—Agitation—Prednisone—prostate cancer	4.91e-05	0.000453	CcSEcCtD
Methadone—Oedema—Capecitabine—prostate cancer	4.9e-05	0.000451	CcSEcCtD
Methadone—Bradycardia—Epirubicin—prostate cancer	4.89e-05	0.000451	CcSEcCtD
Methadone—Modafinil—CYP2C19—prostate cancer	4.87e-05	0.0184	CrCbGaD
Methadone—Urticaria—Etoposide—prostate cancer	4.84e-05	0.000446	CcSEcCtD
Methadone—Tamoxifen—CYP3A5—prostate cancer	4.84e-05	0.0183	CrCbGaD
Methadone—Anorexia—Docetaxel—prostate cancer	4.82e-05	0.000444	CcSEcCtD
Methadone—Shock—Capecitabine—prostate cancer	4.82e-05	0.000444	CcSEcCtD
Methadone—Body temperature increased—Etoposide—prostate cancer	4.81e-05	0.000443	CcSEcCtD
Methadone—Abdominal pain—Etoposide—prostate cancer	4.81e-05	0.000443	CcSEcCtD
Methadone—Vertigo—Prednisone—prostate cancer	4.8e-05	0.000443	CcSEcCtD
Methadone—Thrombocytopenia—Capecitabine—prostate cancer	4.8e-05	0.000442	CcSEcCtD
Methadone—Syncope—Prednisone—prostate cancer	4.8e-05	0.000442	CcSEcCtD
Methadone—Tachycardia—Capecitabine—prostate cancer	4.78e-05	0.00044	CcSEcCtD
Methadone—Sweating—Doxorubicin—prostate cancer	4.75e-05	0.000437	CcSEcCtD
Methadone—Hyperhidrosis—Capecitabine—prostate cancer	4.74e-05	0.000436	CcSEcCtD
Methadone—Hypotension—Docetaxel—prostate cancer	4.73e-05	0.000436	CcSEcCtD
Methadone—Darifenacin—CYP3A4—prostate cancer	4.71e-05	0.0178	CrCbGaD
Methadone—Loss of consciousness—Prednisone—prostate cancer	4.7e-05	0.000433	CcSEcCtD
Methadone—Phenoxybenzamine—ADRB2—prostate cancer	4.68e-05	0.0177	CrCbGaD
Methadone—Tamoxifen—CYP2A6—prostate cancer	4.68e-05	0.0177	CrCbGaD
Methadone—Anorexia—Capecitabine—prostate cancer	4.67e-05	0.00043	CcSEcCtD
Methadone—Nausea—Estradiol—prostate cancer	4.67e-05	0.00043	CcSEcCtD
Methadone—Vomiting—Mitoxantrone—prostate cancer	4.65e-05	0.000429	CcSEcCtD
Methadone—Convulsion—Prednisone—prostate cancer	4.63e-05	0.000427	CcSEcCtD
Methadone—Visual impairment—Epirubicin—prostate cancer	4.63e-05	0.000426	CcSEcCtD
Methadone—Rash—Mitoxantrone—prostate cancer	4.62e-05	0.000425	CcSEcCtD
Methadone—Dermatitis—Mitoxantrone—prostate cancer	4.61e-05	0.000425	CcSEcCtD
Methadone—Headache—Mitoxantrone—prostate cancer	4.59e-05	0.000422	CcSEcCtD
Methadone—Hypotension—Capecitabine—prostate cancer	4.58e-05	0.000422	CcSEcCtD
Methadone—Insomnia—Docetaxel—prostate cancer	4.58e-05	0.000422	CcSEcCtD
Methadone—Anxiety—Prednisone—prostate cancer	4.54e-05	0.000418	CcSEcCtD
Methadone—Bradycardia—Doxorubicin—prostate cancer	4.53e-05	0.000417	CcSEcCtD
Methadone—Somnolence—Docetaxel—prostate cancer	4.5e-05	0.000414	CcSEcCtD
Methadone—Hypersensitivity—Etoposide—prostate cancer	4.49e-05	0.000413	CcSEcCtD
Methadone—Flushing—Epirubicin—prostate cancer	4.46e-05	0.000411	CcSEcCtD
Methadone—Tamoxifen—CYP19A1—prostate cancer	4.46e-05	0.0169	CrCbGaD
Methadone—Insomnia—Capecitabine—prostate cancer	4.43e-05	0.000408	CcSEcCtD
Methadone—Decreased appetite—Docetaxel—prostate cancer	4.4e-05	0.000405	CcSEcCtD
Methadone—Asthenia—Etoposide—prostate cancer	4.37e-05	0.000402	CcSEcCtD
Methadone—Oedema—Prednisone—prostate cancer	4.36e-05	0.000402	CcSEcCtD
Methadone—Anaphylactic shock—Prednisone—prostate cancer	4.36e-05	0.000402	CcSEcCtD
Methadone—Nausea—Mitoxantrone—prostate cancer	4.35e-05	0.000401	CcSEcCtD
Methadone—Disopyramide—CYP3A4—prostate cancer	4.34e-05	0.0164	CrCbGaD
Methadone—Pain—Docetaxel—prostate cancer	4.33e-05	0.000399	CcSEcCtD
Methadone—Constipation—Docetaxel—prostate cancer	4.33e-05	0.000399	CcSEcCtD
Methadone—Chills—Epirubicin—prostate cancer	4.31e-05	0.000397	CcSEcCtD
Methadone—Pruritus—Etoposide—prostate cancer	4.31e-05	0.000397	CcSEcCtD
Methadone—Shock—Prednisone—prostate cancer	4.29e-05	0.000396	CcSEcCtD
Methadone—Arrhythmia—Epirubicin—prostate cancer	4.29e-05	0.000395	CcSEcCtD
Methadone—Visual impairment—Doxorubicin—prostate cancer	4.28e-05	0.000395	CcSEcCtD
Methadone—Tachycardia—Prednisone—prostate cancer	4.26e-05	0.000392	CcSEcCtD
Methadone—Decreased appetite—Capecitabine—prostate cancer	4.26e-05	0.000392	CcSEcCtD
Methadone—Hyperhidrosis—Prednisone—prostate cancer	4.22e-05	0.000389	CcSEcCtD
Methadone—Pain—Capecitabine—prostate cancer	4.19e-05	0.000386	CcSEcCtD
Methadone—Constipation—Capecitabine—prostate cancer	4.19e-05	0.000386	CcSEcCtD
Methadone—Atomoxetine—CYP2C19—prostate cancer	4.19e-05	0.0158	CrCbGaD
Methadone—Erythema—Epirubicin—prostate cancer	4.18e-05	0.000385	CcSEcCtD
Methadone—Feeling abnormal—Docetaxel—prostate cancer	4.17e-05	0.000384	CcSEcCtD
Methadone—Diarrhoea—Etoposide—prostate cancer	4.17e-05	0.000384	CcSEcCtD
Methadone—Anorexia—Prednisone—prostate cancer	4.16e-05	0.000383	CcSEcCtD
Methadone—Gastrointestinal pain—Docetaxel—prostate cancer	4.14e-05	0.000381	CcSEcCtD
Methadone—Flushing—Doxorubicin—prostate cancer	4.13e-05	0.00038	CcSEcCtD
Methadone—Tamoxifen—ESR1—prostate cancer	4.1e-05	0.0155	CrCbGaD
Methadone—Feeling abnormal—Capecitabine—prostate cancer	4.04e-05	0.000372	CcSEcCtD
Methadone—Dizziness—Etoposide—prostate cancer	4.03e-05	0.000371	CcSEcCtD
Methadone—Muscle spasms—Epirubicin—prostate cancer	4.02e-05	0.00037	CcSEcCtD
Methadone—Gastrointestinal pain—Capecitabine—prostate cancer	4.01e-05	0.000369	CcSEcCtD
Methadone—Abdominal pain—Docetaxel—prostate cancer	4e-05	0.000369	CcSEcCtD
Methadone—Body temperature increased—Docetaxel—prostate cancer	4e-05	0.000369	CcSEcCtD
Methadone—Chills—Doxorubicin—prostate cancer	3.99e-05	0.000367	CcSEcCtD
Methadone—Arrhythmia—Doxorubicin—prostate cancer	3.97e-05	0.000366	CcSEcCtD
Methadone—Phenylbutazone—CYP3A4—prostate cancer	3.95e-05	0.015	CrCbGaD
Methadone—Insomnia—Prednisone—prostate cancer	3.95e-05	0.000364	CcSEcCtD
Methadone—Urticaria—Capecitabine—prostate cancer	3.89e-05	0.000359	CcSEcCtD
Methadone—Abdominal pain—Capecitabine—prostate cancer	3.87e-05	0.000357	CcSEcCtD
Methadone—Body temperature increased—Capecitabine—prostate cancer	3.87e-05	0.000357	CcSEcCtD
Methadone—Vomiting—Etoposide—prostate cancer	3.87e-05	0.000357	CcSEcCtD
Methadone—Erythema—Doxorubicin—prostate cancer	3.87e-05	0.000356	CcSEcCtD
Methadone—Phenylbutazone—PTGS2—prostate cancer	3.87e-05	0.0146	CrCbGaD
Methadone—Agitation—Epirubicin—prostate cancer	3.84e-05	0.000354	CcSEcCtD
Methadone—Rash—Etoposide—prostate cancer	3.84e-05	0.000354	CcSEcCtD
Methadone—Dermatitis—Etoposide—prostate cancer	3.84e-05	0.000353	CcSEcCtD
Methadone—Headache—Etoposide—prostate cancer	3.81e-05	0.000351	CcSEcCtD
Methadone—Decreased appetite—Prednisone—prostate cancer	3.79e-05	0.000349	CcSEcCtD
Methadone—Vertigo—Epirubicin—prostate cancer	3.76e-05	0.000346	CcSEcCtD
Methadone—Syncope—Epirubicin—prostate cancer	3.75e-05	0.000345	CcSEcCtD
Methadone—Constipation—Prednisone—prostate cancer	3.73e-05	0.000344	CcSEcCtD
Methadone—Hypersensitivity—Docetaxel—prostate cancer	3.73e-05	0.000343	CcSEcCtD
Methadone—Muscle spasms—Doxorubicin—prostate cancer	3.72e-05	0.000343	CcSEcCtD
Methadone—Palpitations—Epirubicin—prostate cancer	3.7e-05	0.00034	CcSEcCtD
Methadone—Loss of consciousness—Epirubicin—prostate cancer	3.68e-05	0.000339	CcSEcCtD
Methadone—Asthenia—Docetaxel—prostate cancer	3.63e-05	0.000334	CcSEcCtD
Methadone—Convulsion—Epirubicin—prostate cancer	3.62e-05	0.000334	CcSEcCtD
Methadone—Nausea—Etoposide—prostate cancer	3.62e-05	0.000333	CcSEcCtD
Methadone—Hypersensitivity—Capecitabine—prostate cancer	3.61e-05	0.000333	CcSEcCtD
Methadone—Feeling abnormal—Prednisone—prostate cancer	3.6e-05	0.000331	CcSEcCtD
Methadone—Pruritus—Docetaxel—prostate cancer	3.58e-05	0.00033	CcSEcCtD
Methadone—Gastrointestinal pain—Prednisone—prostate cancer	3.57e-05	0.000329	CcSEcCtD
Methadone—Agitation—Doxorubicin—prostate cancer	3.56e-05	0.000328	CcSEcCtD
Methadone—Anxiety—Epirubicin—prostate cancer	3.55e-05	0.000327	CcSEcCtD
Methadone—Clotrimazole—CYP3A4—prostate cancer	3.54e-05	0.0134	CrCbGaD
Methadone—Levomethadyl Acetate—CYP3A4—prostate cancer	3.54e-05	0.0134	CrCbGaD
Methadone—Asthenia—Capecitabine—prostate cancer	3.52e-05	0.000324	CcSEcCtD
Methadone—Dry mouth—Epirubicin—prostate cancer	3.48e-05	0.000321	CcSEcCtD
Methadone—Vertigo—Doxorubicin—prostate cancer	3.48e-05	0.00032	CcSEcCtD
Methadone—Syncope—Doxorubicin—prostate cancer	3.47e-05	0.00032	CcSEcCtD
Methadone—Urticaria—Prednisone—prostate cancer	3.47e-05	0.000319	CcSEcCtD
Methadone—Pruritus—Capecitabine—prostate cancer	3.47e-05	0.000319	CcSEcCtD
Methadone—Diarrhoea—Docetaxel—prostate cancer	3.46e-05	0.000319	CcSEcCtD
Methadone—Body temperature increased—Prednisone—prostate cancer	3.45e-05	0.000318	CcSEcCtD
Methadone—Abdominal pain—Prednisone—prostate cancer	3.45e-05	0.000318	CcSEcCtD
Methadone—Trimipramine—CYP2C19—prostate cancer	3.44e-05	0.013	CrCbGaD
Methadone—Confusional state—Epirubicin—prostate cancer	3.44e-05	0.000317	CcSEcCtD
Methadone—Palpitations—Doxorubicin—prostate cancer	3.42e-05	0.000315	CcSEcCtD
Methadone—Oedema—Epirubicin—prostate cancer	3.41e-05	0.000314	CcSEcCtD
Methadone—Anaphylactic shock—Epirubicin—prostate cancer	3.41e-05	0.000314	CcSEcCtD
Methadone—Loss of consciousness—Doxorubicin—prostate cancer	3.4e-05	0.000313	CcSEcCtD
Methadone—Diphenhydramine—CYP2C19—prostate cancer	3.38e-05	0.0128	CrCbGaD
Methadone—Shock—Epirubicin—prostate cancer	3.36e-05	0.000309	CcSEcCtD
Methadone—Convulsion—Doxorubicin—prostate cancer	3.35e-05	0.000309	CcSEcCtD
Methadone—Diarrhoea—Capecitabine—prostate cancer	3.35e-05	0.000309	CcSEcCtD
Methadone—Dizziness—Docetaxel—prostate cancer	3.35e-05	0.000308	CcSEcCtD
Methadone—Thrombocytopenia—Epirubicin—prostate cancer	3.34e-05	0.000308	CcSEcCtD
Methadone—Tachycardia—Epirubicin—prostate cancer	3.33e-05	0.000307	CcSEcCtD
Methadone—Tamoxifen—CYP2E1—prostate cancer	3.32e-05	0.0126	CrCbGaD
Methadone—Hyperhidrosis—Epirubicin—prostate cancer	3.3e-05	0.000304	CcSEcCtD
Methadone—Tamoxifen—CYP2C19—prostate cancer	3.29e-05	0.0125	CrCbGaD
Methadone—Anxiety—Doxorubicin—prostate cancer	3.28e-05	0.000302	CcSEcCtD
Methadone—Tamoxifen—CYP1A1—prostate cancer	3.28e-05	0.0124	CrCbGaD
Methadone—Anorexia—Epirubicin—prostate cancer	3.25e-05	0.0003	CcSEcCtD
Methadone—Dizziness—Capecitabine—prostate cancer	3.24e-05	0.000298	CcSEcCtD
Methadone—Orphenadrine—CYP2E1—prostate cancer	3.23e-05	0.0122	CrCbGaD
Methadone—Dry mouth—Doxorubicin—prostate cancer	3.22e-05	0.000297	CcSEcCtD
Methadone—Vomiting—Docetaxel—prostate cancer	3.22e-05	0.000296	CcSEcCtD
Methadone—Hypersensitivity—Prednisone—prostate cancer	3.22e-05	0.000296	CcSEcCtD
Methadone—Rash—Docetaxel—prostate cancer	3.19e-05	0.000294	CcSEcCtD
Methadone—Hypotension—Epirubicin—prostate cancer	3.19e-05	0.000294	CcSEcCtD
Methadone—Dermatitis—Docetaxel—prostate cancer	3.19e-05	0.000294	CcSEcCtD
Methadone—Confusional state—Doxorubicin—prostate cancer	3.18e-05	0.000293	CcSEcCtD
Methadone—Headache—Docetaxel—prostate cancer	3.17e-05	0.000292	CcSEcCtD
Methadone—Anaphylactic shock—Doxorubicin—prostate cancer	3.16e-05	0.000291	CcSEcCtD
Methadone—Oedema—Doxorubicin—prostate cancer	3.16e-05	0.000291	CcSEcCtD
Methadone—Asthenia—Prednisone—prostate cancer	3.13e-05	0.000288	CcSEcCtD
Methadone—Vomiting—Capecitabine—prostate cancer	3.11e-05	0.000287	CcSEcCtD
Methadone—Shock—Doxorubicin—prostate cancer	3.11e-05	0.000286	CcSEcCtD
Methadone—Modafinil—CYP3A4—prostate cancer	3.09e-05	0.0117	CrCbGaD
Methadone—Thrombocytopenia—Doxorubicin—prostate cancer	3.09e-05	0.000285	CcSEcCtD
Methadone—Rash—Capecitabine—prostate cancer	3.09e-05	0.000285	CcSEcCtD
Methadone—Pruritus—Prednisone—prostate cancer	3.09e-05	0.000284	CcSEcCtD
Methadone—Insomnia—Epirubicin—prostate cancer	3.09e-05	0.000284	CcSEcCtD
Methadone—Dermatitis—Capecitabine—prostate cancer	3.09e-05	0.000284	CcSEcCtD
Methadone—Tachycardia—Doxorubicin—prostate cancer	3.08e-05	0.000284	CcSEcCtD
Methadone—Headache—Capecitabine—prostate cancer	3.07e-05	0.000283	CcSEcCtD
Methadone—Dextropropoxyphene—CYP3A4—prostate cancer	3.06e-05	0.0116	CrCbGaD
Methadone—Hyperhidrosis—Doxorubicin—prostate cancer	3.05e-05	0.000281	CcSEcCtD
Methadone—Somnolence—Epirubicin—prostate cancer	3.03e-05	0.00028	CcSEcCtD
Methadone—Fentanyl—CYP3A4—prostate cancer	3.03e-05	0.0115	CrCbGaD
Methadone—Anorexia—Doxorubicin—prostate cancer	3.01e-05	0.000277	CcSEcCtD
Methadone—Nausea—Docetaxel—prostate cancer	3.01e-05	0.000277	CcSEcCtD
Methadone—Diarrhoea—Prednisone—prostate cancer	2.99e-05	0.000275	CcSEcCtD
Methadone—Decreased appetite—Epirubicin—prostate cancer	2.97e-05	0.000273	CcSEcCtD
Methadone—Hypotension—Doxorubicin—prostate cancer	2.95e-05	0.000272	CcSEcCtD
Methadone—Pain—Epirubicin—prostate cancer	2.92e-05	0.000269	CcSEcCtD
Methadone—Constipation—Epirubicin—prostate cancer	2.92e-05	0.000269	CcSEcCtD
Methadone—Loperamide—CYP3A4—prostate cancer	2.92e-05	0.011	CrCbGaD
Methadone—Nausea—Capecitabine—prostate cancer	2.91e-05	0.000268	CcSEcCtD
Methadone—Dizziness—Prednisone—prostate cancer	2.89e-05	0.000266	CcSEcCtD
Methadone—Insomnia—Doxorubicin—prostate cancer	2.86e-05	0.000263	CcSEcCtD
Methadone—Feeling abnormal—Epirubicin—prostate cancer	2.81e-05	0.000259	CcSEcCtD
Methadone—Somnolence—Doxorubicin—prostate cancer	2.81e-05	0.000259	CcSEcCtD
Methadone—Gastrointestinal pain—Epirubicin—prostate cancer	2.79e-05	0.000257	CcSEcCtD
Methadone—Vomiting—Prednisone—prostate cancer	2.77e-05	0.000256	CcSEcCtD
Methadone—Rash—Prednisone—prostate cancer	2.75e-05	0.000253	CcSEcCtD
Methadone—Dermatitis—Prednisone—prostate cancer	2.75e-05	0.000253	CcSEcCtD
Methadone—Decreased appetite—Doxorubicin—prostate cancer	2.75e-05	0.000253	CcSEcCtD
Methadone—Headache—Prednisone—prostate cancer	2.73e-05	0.000252	CcSEcCtD
Methadone—Urticaria—Epirubicin—prostate cancer	2.71e-05	0.00025	CcSEcCtD
Methadone—Pain—Doxorubicin—prostate cancer	2.7e-05	0.000249	CcSEcCtD
Methadone—Constipation—Doxorubicin—prostate cancer	2.7e-05	0.000249	CcSEcCtD
Methadone—Abdominal pain—Epirubicin—prostate cancer	2.7e-05	0.000249	CcSEcCtD
Methadone—Body temperature increased—Epirubicin—prostate cancer	2.7e-05	0.000249	CcSEcCtD
Methadone—Benzphetamine—CYP3A4—prostate cancer	2.68e-05	0.0102	CrCbGaD
Methadone—Atomoxetine—CYP3A4—prostate cancer	2.66e-05	0.0101	CrCbGaD
Methadone—Feeling abnormal—Doxorubicin—prostate cancer	2.6e-05	0.00024	CcSEcCtD
Methadone—Nausea—Prednisone—prostate cancer	2.59e-05	0.000239	CcSEcCtD
Methadone—Gastrointestinal pain—Doxorubicin—prostate cancer	2.58e-05	0.000238	CcSEcCtD
Methadone—Phenoxybenzamine—CYP3A4—prostate cancer	2.56e-05	0.0097	CrCbGaD
Methadone—Hypersensitivity—Epirubicin—prostate cancer	2.51e-05	0.000232	CcSEcCtD
Methadone—Urticaria—Doxorubicin—prostate cancer	2.51e-05	0.000231	CcSEcCtD
Methadone—Body temperature increased—Doxorubicin—prostate cancer	2.5e-05	0.00023	CcSEcCtD
Methadone—Abdominal pain—Doxorubicin—prostate cancer	2.5e-05	0.00023	CcSEcCtD
Methadone—Asthenia—Epirubicin—prostate cancer	2.45e-05	0.000226	CcSEcCtD
Methadone—Pruritus—Epirubicin—prostate cancer	2.41e-05	0.000222	CcSEcCtD
Methadone—Diarrhoea—Epirubicin—prostate cancer	2.34e-05	0.000215	CcSEcCtD
Methadone—Hypersensitivity—Doxorubicin—prostate cancer	2.33e-05	0.000214	CcSEcCtD
Methadone—Asthenia—Doxorubicin—prostate cancer	2.27e-05	0.000209	CcSEcCtD
Methadone—Dizziness—Epirubicin—prostate cancer	2.26e-05	0.000208	CcSEcCtD
Methadone—Pruritus—Doxorubicin—prostate cancer	2.23e-05	0.000206	CcSEcCtD
Methadone—Trimipramine—CYP3A4—prostate cancer	2.19e-05	0.00829	CrCbGaD
Methadone—Vomiting—Epirubicin—prostate cancer	2.17e-05	0.0002	CcSEcCtD
Methadone—Diarrhoea—Doxorubicin—prostate cancer	2.16e-05	0.000199	CcSEcCtD
Methadone—Rash—Epirubicin—prostate cancer	2.15e-05	0.000198	CcSEcCtD
Methadone—Dermatitis—Epirubicin—prostate cancer	2.15e-05	0.000198	CcSEcCtD
Methadone—Headache—Epirubicin—prostate cancer	2.14e-05	0.000197	CcSEcCtD
Methadone—Tamoxifen—CYP3A4—prostate cancer	2.09e-05	0.00792	CrCbGaD
Methadone—Dizziness—Doxorubicin—prostate cancer	2.09e-05	0.000192	CcSEcCtD
Methadone—Orphenadrine—CYP3A4—prostate cancer	2.03e-05	0.0077	CrCbGaD
Methadone—Nausea—Epirubicin—prostate cancer	2.03e-05	0.000187	CcSEcCtD
Methadone—Vomiting—Doxorubicin—prostate cancer	2.01e-05	0.000185	CcSEcCtD
Methadone—Rash—Doxorubicin—prostate cancer	1.99e-05	0.000183	CcSEcCtD
Methadone—Dermatitis—Doxorubicin—prostate cancer	1.99e-05	0.000183	CcSEcCtD
Methadone—Headache—Doxorubicin—prostate cancer	1.98e-05	0.000182	CcSEcCtD
Methadone—Nausea—Doxorubicin—prostate cancer	1.88e-05	0.000173	CcSEcCtD
Methadone—OPRM1—Signaling Pathways—ERBB2—prostate cancer	1.36e-06	1.41e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—TH—prostate cancer	1.36e-06	1.4e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—GSTP1—prostate cancer	1.36e-06	1.4e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—GSTM1—prostate cancer	1.36e-06	1.4e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—COMT—prostate cancer	1.35e-06	1.4e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.35e-06	1.4e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—GSTP1—prostate cancer	1.35e-06	1.39e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—CYP3A4—prostate cancer	1.34e-06	1.39e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—MTHFR—prostate cancer	1.34e-06	1.39e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—PIK3CB—prostate cancer	1.34e-06	1.39e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—TYMS—prostate cancer	1.34e-06	1.38e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—AKT1—prostate cancer	1.34e-06	1.38e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.34e-06	1.38e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—ITPR1—prostate cancer	1.34e-06	1.38e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—PIK3CG—prostate cancer	1.33e-06	1.38e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—LPL—prostate cancer	1.33e-06	1.38e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—ITPR1—prostate cancer	1.32e-06	1.37e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—GSTM1—prostate cancer	1.32e-06	1.37e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—CYP1B1—prostate cancer	1.32e-06	1.37e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—HPGDS—prostate cancer	1.32e-06	1.36e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—PPARA—prostate cancer	1.32e-06	1.36e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—CYP2C19—prostate cancer	1.31e-06	1.36e-05	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—EP300—prostate cancer	1.31e-06	1.35e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—EP300—prostate cancer	1.31e-06	1.35e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—PIK3CG—prostate cancer	1.3e-06	1.35e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.3e-06	1.35e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—MYC—prostate cancer	1.3e-06	1.34e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—LPL—prostate cancer	1.3e-06	1.34e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—TGFB1—prostate cancer	1.3e-06	1.34e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—CXCL8—prostate cancer	1.29e-06	1.33e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—CYP1A1—prostate cancer	1.29e-06	1.33e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—GSTT1—prostate cancer	1.28e-06	1.32e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—ACHE—prostate cancer	1.28e-06	1.32e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—GGT1—prostate cancer	1.28e-06	1.32e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—ERCC2—prostate cancer	1.28e-06	1.32e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—SRC—prostate cancer	1.27e-06	1.32e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—EGFR—prostate cancer	1.27e-06	1.32e-05	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—PIK3CA—prostate cancer	1.27e-06	1.31e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—CYP2A6—prostate cancer	1.27e-06	1.31e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—TYMS—prostate cancer	1.26e-06	1.3e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—INS—prostate cancer	1.26e-06	1.3e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—NCOA1—prostate cancer	1.26e-06	1.3e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—CDKN1B—prostate cancer	1.26e-06	1.3e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—CYP1A1—prostate cancer	1.26e-06	1.3e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—TYMS—prostate cancer	1.25e-06	1.29e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—GSTM1—prostate cancer	1.25e-06	1.29e-05	CbGpPWpGaD
Methadone—OPRM1—GPCR downstream signaling—AKT1—prostate cancer	1.25e-06	1.29e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—ERCC2—prostate cancer	1.24e-06	1.29e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—CYP19A1—prostate cancer	1.24e-06	1.29e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—VEGFA—prostate cancer	1.24e-06	1.28e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—CAV1—prostate cancer	1.24e-06	1.28e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—GSTM1—prostate cancer	1.24e-06	1.28e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—CREBBP—prostate cancer	1.24e-06	1.28e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—CASP3—prostate cancer	1.23e-06	1.28e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—INS—prostate cancer	1.23e-06	1.27e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—IL2—prostate cancer	1.23e-06	1.27e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—AKR1C3—prostate cancer	1.23e-06	1.27e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—STAT3—prostate cancer	1.23e-06	1.27e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—IL6—prostate cancer	1.23e-06	1.27e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—PRKACB—prostate cancer	1.22e-06	1.27e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—LPL—prostate cancer	1.22e-06	1.27e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—LPL—prostate cancer	1.21e-06	1.26e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—CYP17A1—prostate cancer	1.21e-06	1.25e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—CREBBP—prostate cancer	1.21e-06	1.25e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—KRAS—prostate cancer	1.2e-06	1.24e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—CCND1—prostate cancer	1.2e-06	1.24e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—RXRA—prostate cancer	1.2e-06	1.24e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—MTHFR—prostate cancer	1.2e-06	1.24e-05	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—PTEN—prostate cancer	1.19e-06	1.23e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—CTNNB1—prostate cancer	1.19e-06	1.23e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.18e-06	1.22e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—CYP1A1—prostate cancer	1.18e-06	1.22e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—PPARA—prostate cancer	1.18e-06	1.22e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—ERCC2—prostate cancer	1.17e-06	1.21e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—CYP1A1—prostate cancer	1.17e-06	1.21e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—PIK3CD—prostate cancer	1.17e-06	1.21e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—MTHFR—prostate cancer	1.17e-06	1.21e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—MMP9—prostate cancer	1.17e-06	1.21e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.17e-06	1.21e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—ERCC2—prostate cancer	1.16e-06	1.2e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—CDKN1A—prostate cancer	1.16e-06	1.2e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—PTEN—prostate cancer	1.16e-06	1.2e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—COMT—prostate cancer	1.16e-06	1.19e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—NCOA2—prostate cancer	1.16e-06	1.19e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—GSTP1—prostate cancer	1.15e-06	1.19e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—PPARA—prostate cancer	1.15e-06	1.19e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—PIK3CD—prostate cancer	1.15e-06	1.18e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—MYC—prostate cancer	1.14e-06	1.18e-05	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—EP300—prostate cancer	1.14e-06	1.18e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—TGFB1—prostate cancer	1.14e-06	1.18e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—AKT1—prostate cancer	1.13e-06	1.17e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—ITPR1—prostate cancer	1.13e-06	1.17e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—PIK3CG—prostate cancer	1.13e-06	1.17e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—EGFR—prostate cancer	1.12e-06	1.15e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.11e-06	1.15e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—EP300—prostate cancer	1.11e-06	1.14e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—NOS3—prostate cancer	1.11e-06	1.14e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—CAV1—prostate cancer	1.11e-06	1.14e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—PIK3CA—prostate cancer	1.1e-06	1.14e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—MTHFR—prostate cancer	1.1e-06	1.14e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—SLC5A5—prostate cancer	1.1e-06	1.14e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—MTHFR—prostate cancer	1.09e-06	1.13e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—PPARA—prostate cancer	1.08e-06	1.12e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—NOS3—prostate cancer	1.08e-06	1.12e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—CAV1—prostate cancer	1.08e-06	1.12e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—CYP2E1—prostate cancer	1.08e-06	1.11e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—SRC—prostate cancer	1.08e-06	1.11e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—PPARA—prostate cancer	1.07e-06	1.11e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—TYMS—prostate cancer	1.07e-06	1.11e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—TP53—prostate cancer	1.07e-06	1.1e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—INS—prostate cancer	1.07e-06	1.1e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—NQO1—prostate cancer	1.06e-06	1.1e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—GSTM1—prostate cancer	1.06e-06	1.09e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.06e-06	1.09e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—KRAS—prostate cancer	1.05e-06	1.09e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—TH—prostate cancer	1.05e-06	1.08e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—VEGFA—prostate cancer	1.05e-06	1.08e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—CREBBP—prostate cancer	1.05e-06	1.08e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—STAT3—prostate cancer	1.04e-06	1.07e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—LPL—prostate cancer	1.04e-06	1.07e-05	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—AKT1—prostate cancer	1.03e-06	1.07e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—PIK3CB—prostate cancer	1.02e-06	1.06e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—CYP1B1—prostate cancer	1.02e-06	1.05e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—CAV1—prostate cancer	1.02e-06	1.05e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—PTGS2—prostate cancer	1.01e-06	1.05e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—CAV1—prostate cancer	1.01e-06	1.04e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—PIK3CG—prostate cancer	1.01e-06	1.04e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—CYP1A1—prostate cancer	1e-06	1.04e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—PIK3CB—prostate cancer	9.98e-07	1.03e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—ERCC2—prostate cancer	9.94e-07	1.03e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—PIK3CD—prostate cancer	9.92e-07	1.03e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—PTGS2—prostate cancer	9.89e-07	1.02e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—GGT1—prostate cancer	9.88e-07	1.02e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—PIK3CG—prostate cancer	9.83e-07	1.02e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—IL6—prostate cancer	9.78e-07	1.01e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—NCOA1—prostate cancer	9.73e-07	1.01e-05	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—PIK3CA—prostate cancer	9.69e-07	1e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—PIK3CA—prostate cancer	9.68e-07	1e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—MYC—prostate cancer	9.64e-07	9.97e-06	CbGpPWpGaD
Methadone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	9.63e-07	9.96e-06	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—TGFB1—prostate cancer	9.62e-07	9.94e-06	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—CYP19A1—prostate cancer	9.59e-07	9.92e-06	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—INS—prostate cancer	9.53e-07	9.86e-06	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—EGFR—prostate cancer	9.43e-07	9.75e-06	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—TP53—prostate cancer	9.37e-07	9.69e-06	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—NOS3—prostate cancer	9.37e-07	9.68e-06	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—MTHFR—prostate cancer	9.34e-07	9.66e-06	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—CREBBP—prostate cancer	9.34e-07	9.65e-06	CbGpPWpGaD
Methadone—ABCB1—Metabolism—INS—prostate cancer	9.31e-07	9.62e-06	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—PIK3CG—prostate cancer	9.26e-07	9.58e-06	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—RXRA—prostate cancer	9.26e-07	9.57e-06	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—PIK3CG—prostate cancer	9.18e-07	9.49e-06	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—PPARA—prostate cancer	9.16e-07	9.47e-06	CbGpPWpGaD
Methadone—ABCB1—Metabolism—CREBBP—prostate cancer	9.11e-07	9.42e-06	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—AKT1—prostate cancer	9.02e-07	9.33e-06	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—COMT—prostate cancer	8.92e-07	9.22e-06	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—KRAS—prostate cancer	8.91e-07	9.21e-06	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—GSTP1—prostate cancer	8.88e-07	9.18e-06	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—PIK3CD—prostate cancer	8.85e-07	9.15e-06	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—PTEN—prostate cancer	8.82e-07	9.12e-06	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—INS—prostate cancer	8.77e-07	9.07e-06	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—ITPR1—prostate cancer	8.73e-07	9.03e-06	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—INS—prostate cancer	8.69e-07	8.99e-06	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—PIK3CB—prostate cancer	8.65e-07	8.94e-06	CbGpPWpGaD
Methadone—ABCB1—Metabolism—PIK3CD—prostate cancer	8.64e-07	8.93e-06	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—PTEN—prostate cancer	8.63e-07	8.92e-06	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—CAV1—prostate cancer	8.62e-07	8.91e-06	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—CREBBP—prostate cancer	8.59e-07	8.88e-06	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—IL6—prostate cancer	8.58e-07	8.87e-06	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—PTGS2—prostate cancer	8.57e-07	8.86e-06	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—CREBBP—prostate cancer	8.51e-07	8.8e-06	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—PIK3CA—prostate cancer	8.42e-07	8.7e-06	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—EP300—prostate cancer	8.42e-07	8.7e-06	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—NOS3—prostate cancer	8.36e-07	8.64e-06	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—TYMS—prostate cancer	8.25e-07	8.53e-06	CbGpPWpGaD
Methadone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	8.23e-07	8.51e-06	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—EP300—prostate cancer	8.23e-07	8.5e-06	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—PIK3CA—prostate cancer	8.18e-07	8.46e-06	CbGpPWpGaD
Methadone—ABCB1—Metabolism—NOS3—prostate cancer	8.16e-07	8.44e-06	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—GSTM1—prostate cancer	8.16e-07	8.43e-06	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—PIK3CD—prostate cancer	8.14e-07	8.42e-06	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—PIK3CD—prostate cancer	8.07e-07	8.35e-06	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—LPL—prostate cancer	8.01e-07	8.28e-06	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—AKT1—prostate cancer	7.92e-07	8.19e-06	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—TP53—prostate cancer	7.92e-07	8.19e-06	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—AKT1—prostate cancer	7.91e-07	8.18e-06	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—PIK3CG—prostate cancer	7.85e-07	8.11e-06	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—CYP1A1—prostate cancer	7.73e-07	7.99e-06	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—PIK3CB—prostate cancer	7.72e-07	7.98e-06	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—NOS3—prostate cancer	7.69e-07	7.95e-06	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—ERCC2—prostate cancer	7.67e-07	7.93e-06	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—PTGS2—prostate cancer	7.65e-07	7.91e-06	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—NOS3—prostate cancer	7.62e-07	7.88e-06	CbGpPWpGaD
Methadone—ABCB1—Metabolism—PIK3CB—prostate cancer	7.53e-07	7.79e-06	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—PTEN—prostate cancer	7.47e-07	7.72e-06	CbGpPWpGaD
Methadone—ABCB1—Metabolism—PTGS2—prostate cancer	7.46e-07	7.72e-06	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—INS—prostate cancer	7.43e-07	7.68e-06	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—CREBBP—prostate cancer	7.28e-07	7.52e-06	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—IL6—prostate cancer	7.25e-07	7.49e-06	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—MTHFR—prostate cancer	7.21e-07	7.45e-06	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—EP300—prostate cancer	7.13e-07	7.37e-06	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—PIK3CB—prostate cancer	7.1e-07	7.34e-06	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—PPARA—prostate cancer	7.07e-07	7.31e-06	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—PIK3CB—prostate cancer	7.04e-07	7.27e-06	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—PTGS2—prostate cancer	7.03e-07	7.27e-06	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—PTGS2—prostate cancer	6.97e-07	7.21e-06	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—PIK3CD—prostate cancer	6.9e-07	7.13e-06	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—AKT1—prostate cancer	6.88e-07	7.11e-06	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—AKT1—prostate cancer	6.69e-07	6.91e-06	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—PTEN—prostate cancer	6.67e-07	6.89e-06	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—CAV1—prostate cancer	6.65e-07	6.87e-06	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—NOS3—prostate cancer	6.51e-07	6.73e-06	CbGpPWpGaD
Methadone—ABCB1—Metabolism—PTEN—prostate cancer	6.51e-07	6.73e-06	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—EP300—prostate cancer	6.36e-07	6.57e-06	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—PIK3CA—prostate cancer	6.23e-07	6.44e-06	CbGpPWpGaD
Methadone—ABCB1—Metabolism—EP300—prostate cancer	6.21e-07	6.42e-06	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—PTEN—prostate cancer	6.13e-07	6.34e-06	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—PIK3CA—prostate cancer	6.09e-07	6.29e-06	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—PTEN—prostate cancer	6.08e-07	6.29e-06	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—PIK3CG—prostate cancer	6.06e-07	6.26e-06	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—PIK3CB—prostate cancer	6.01e-07	6.22e-06	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—PTGS2—prostate cancer	5.96e-07	6.16e-06	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—EP300—prostate cancer	5.85e-07	6.05e-06	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—EP300—prostate cancer	5.8e-07	6e-06	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—INS—prostate cancer	5.73e-07	5.93e-06	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—CREBBP—prostate cancer	5.62e-07	5.81e-06	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—PIK3CD—prostate cancer	5.32e-07	5.5e-06	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—PIK3CA—prostate cancer	5.27e-07	5.45e-06	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—PTEN—prostate cancer	5.2e-07	5.37e-06	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—AKT1—prostate cancer	5.09e-07	5.26e-06	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—NOS3—prostate cancer	5.03e-07	5.2e-06	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—AKT1—prostate cancer	4.97e-07	5.14e-06	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—EP300—prostate cancer	4.96e-07	5.12e-06	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—PIK3CA—prostate cancer	4.7e-07	4.86e-06	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—PIK3CB—prostate cancer	4.64e-07	4.8e-06	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—PTGS2—prostate cancer	4.6e-07	4.75e-06	CbGpPWpGaD
Methadone—ABCB1—Metabolism—PIK3CA—prostate cancer	4.59e-07	4.75e-06	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—PIK3CA—prostate cancer	4.33e-07	4.47e-06	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—AKT1—prostate cancer	4.31e-07	4.45e-06	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—PIK3CA—prostate cancer	4.29e-07	4.43e-06	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—PTEN—prostate cancer	4.01e-07	4.15e-06	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—AKT1—prostate cancer	3.84e-07	3.97e-06	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—EP300—prostate cancer	3.82e-07	3.95e-06	CbGpPWpGaD
Methadone—ABCB1—Metabolism—AKT1—prostate cancer	3.75e-07	3.88e-06	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—PIK3CA—prostate cancer	3.67e-07	3.79e-06	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—AKT1—prostate cancer	3.53e-07	3.65e-06	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—AKT1—prostate cancer	3.5e-07	3.62e-06	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—AKT1—prostate cancer	2.99e-07	3.1e-06	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—PIK3CA—prostate cancer	2.83e-07	2.92e-06	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—AKT1—prostate cancer	2.31e-07	2.39e-06	CbGpPWpGaD
